| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CEN
|
54.00 | 568.7M | 4.56 | 0.81 | 1.05 | 11.4% | 10.2% | 83 | 65 | 117.18 | +87.7% | 82 | 0.27 |
|
DKUPL
|
24.60 | 98.0M | 2.56 | 3.28 | 1.49 | 19.5% | 9.1% | 83 | 76 | 48.43 | +72.6% | 69 | 2.84 |
|
DBG
|
9.22 | 1.5B | 2.74 | 1.23 | 2.20 | 7.3% | 9.1% | 81 | 62 | 18.57 | +75.9% | 67 | 0.73 |
|
SDG
|
27.90 | 637.2M | 2.94 | 0.85 | 0.79 | 16.8% | 11.1% | 81 | 73 | 72.14 | +118.9% | 83 | 0.16 |
|
IPS
|
38.60 | 1.6B | 2.32 | 1.06 | 1.56 | 11.9% | 9.9% | 80 | 66 | 89.69 | +99.3% | 73 | 0.42 |
|
WAVE
|
33.55 | 823.8M | 2.51 | 1.18 | 1.38 | 14.0% | 12.3% | 79 | 65 | 75.77 | +94.4% | 85 | 0.03 |
|
TEP
|
69.70 | 4.1B | 2.18 | 0.94 | 1.27 | 9.4% | 7.0% | 78 | 68 | 172.27 | +110.4% | 66 | 1.17 |
|
ALFRE
|
2.68 | 151.4M | 1.62 | 0.82 | 1.53 | 8.5% | 9.5% | 77 | 47 | 5.43 | +73.9% | 78 | 0.61 |
|
EDEN
|
30.08 | 7.1B | 3.54 | — | 2.06 | 77.9% | 8.1% | 76 | 83 | 58.56 | +70.0% | 81 | -5.19 |
|
ELIS
|
23.94 | 5.2B | 3.42 | 1.50 | 1.56 | 6.2% | 7.6% | 72 | 63 | 45.45 | +67.4% | 63 | 1.40 |
|
GLO
|
29.50 | 868.7M | 2.55 | 1.58 | 2.35 | 8.1% | 6.4% | 72 | 63 | 58.39 | +70.5% | 58 | 3.24 |
|
AUB
|
54.90 | 699.1M | 4.58 | 2.41 | 3.06 | 15.1% | 11.8% | 69 | 61 | 79.42 | +33.5% | 84 | 0.22 |
|
DEC
|
23.56 | 5.0B | 3.83 | 2.18 | 2.32 | 7.2% | 8.0% | 68 | 61 | 38.11 | +46.3% | 66 | 1.70 |
|
BVI
|
27.28 | 12.1B | 6.01 | 7.31 | 2.90 | 19.0% | 9.1% | 68 | 69 | 33.27 | +16.5% | 66 | 1.84 |
|
SPIE
|
43.54 | 7.4B | 6.11 | 3.53 | 3.11 | 8.4% | 8.8% | 65 | 57 | 55.11 | +19.9% | 61 | 1.73 |
|
ERF
|
72.54 | 12.6B | 6.70 | 3.50 | 2.67 | 9.3% | 8.6% | 64 | 56 | 85.01 | +12.9% | 65 | 1.24 |
|
WLN
|
13.70 | 775.1M | — | 1.20 | 1.77 | 3.3% | 5.2% | 61 | 61 | 28.06 | +63.9% | 61 | 4.65 |
|
ALCRB
|
6.20 | 104.6M | — | 0.54 | — | — | — | 60 | 36 | 16.88 | +82.6% | 97 | 0.16 |
|
AAA
|
1.56 | 70.6M | — | 1.79 | 2.57 | 5.9% | 7.0% | 55 | 59 | 2.26 | +28.8% | 50 | 4.42 |
|
ALCPB
|
0.53 | 195.7M | — | 1.10 | 1.50 | -1.7% | 10.4% | 48 | 33 | 0.68 | +15.1% | 56 | 0.56 |
|
CBDG
|
102.00 | 6.2B | 51.60 | 1.28 | — | -0.4% | 11.4% | 32 | 21 | 78.73 | -12.8% | 73 | 0.01 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.